Following newly reported financial information, IBO has updated quarterly sales and operating profit results for the Laboratory Sales Index that appeared in the November 15, 2013, issue. Third quarter 2013 Index sales grew 1.5%, 0.8% excluding currency, to $5,904 million. Operating profit climbed 2.7% to $1,206 million, and operating margin advanced 20 basis points to […]
Company Announcements Shimadzu Analytical Instruments opened a Taiwanese subsidiary in November 2013. In November 2013, Imspex Diagnostics acquired GAS, a provider of ion mobility spectrometry technology. For the fiscal half year ending September 28, 2013, Halma Environmental & Analysis revenue grew 9.4%, 3% organically, to £82.6 million ($127.3 million) to make up 25% of revenues […]
To start the year, volatility returned to the equity markets as a consequence of mixed corporate earnings and slower jobs growth in the US, financial turmoil in emerging markets and weak manufacturing data for China. Adding to the anxieties, the US Federal Reserve reduced its monthly asset purchases by another $10 billion to $65 billion. […]
On January 17, more than three months into fiscal year 2014 (FY14), President Obama signed the Consolidated Appropriations Act of 2014. The omnibus bill will fund the federal government at a level of $1.1 trillion and will be effective through September 30. It restores support for many science programs to levels before the FY13 budget […]
CROs are projected to be the leading growth market for the instrument industry in 2014. Pharmaceutical and biotechnology firms are increasingly outsourcing analytical research activities and clinical trials, especially those located in China. The CRO market is followed closely by biotech, agriculture/food, hospital/clinical and pharmaceutical labs, all with similar analysis requirements, especially utilizing mass spectrometry […]
The life science instrumentation (LSI) market is the largest technology sector of the instrument market. It accounts for nearly a quarter of total analytical instruments demand and includes a broad spectrum of technologies grouped into 13 technology categories. In 2013, the LSI market increased 3.3% to $11.1 billion. Most LSI technologies are heavily reliant on […]
The separations market accounts for 17% of the total analytical and life sciences instrumentation industry and increased 1.5% to $7.6 billion in 2013. Demand was mainly driven by the aftermarket and service, while demand for initial systems increased about 1% for the year. Capital expenditures by industrial segments, such as pharmaceutical and chemical markets, were […]
Washington, DC 1/14/14; San Francisco, CA 1/14/14—During its presentation at the J.P. Morgan Healthcare Conference, Illumina announced its financial guidance for 2014 and made announcements regarding its sequencing and diagnostics businesses. For 2014, the company forecast revenues to grow 15%–17% and non-GAAP diluted EPS to be $2.00–$2.06. Gross margins are expected to be 70%. The […]
The instrument industry’s performance in 2013 was even more disappointing than in 2012, as a modest rebound was anticipated. Widespread economic malaise and disruptive budgeting decisions, especially in the US, generated considerable uncertainty about future business prospects. Such uncertainty negatively impacted lab capital expenditures. The very real economic effects of budget sequestration in the US […]
All four IBO Stock Indexes recorded strong double-digit gains in 2013 to end at record levels. Returns for the IBO Stock Indexes were the strongest since 2009, following the recession. Just as strong were US equity markets, which celebrated one of their best years ever and the best returns in six years despite modest economic […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
